| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |